Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus
Jh. Shao et al., Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus, AM J OBST G, 183(5), 2000, pp. 1263-1270
OBJECTIVE: We compared the insulin-mimetic effects of vanadate, a protein-t
yrosine phosphatase inhibitor, with the effects of insulin on skeletal musc
le glucose transport and insulin receptor and insulin receptor substrate 1
phosphorylation to test the hypothesis that protein-tyrosine phosphatases p
articipate in pregnancy-induced insulin resistance.
STUDY DESIGN: Skeletal muscle fiber strips were obtained from the rectus ab
dominis during cesarean delivery in 7 patients with gestational diabetes me
llitus, 11 pregnant women with normal glucose tolerance (pregnant control g
roup), and 11 nonpregnant women undergoing elective surgery (nonpregnant co
ntrol group). Muscle tissues were incubated in vitro for 15 to 60 minutes w
ith or without maximal insulin (100 nmol/L) or sodium vanadate (6 mu mol/L)
. Insulin receptor and insulin receptor substrate 1 tyrosine phosphorylatio
n were measured, as was 2-deoxyglucose transport. The levels of protein-tyr
osine phosphatase 1B were measured by Western blot analysis.
RESULTS: Vanadate stimulated maximal 2-deoxyglucose transport more than did
insulin alone in all samples (P < .05), but the value was still less in mu
scle tissues from pregnant control subjects and patients with gestational d
iabetes mellitus (P < .05). In muscle tissues from pregnant control subject
s vanadate increased tyrosine phosphorylation oi the insulin receptor and i
nsulin receptor substrate 1 to levels similar to those in muscle tissues fr
om nonpregnant control subjects. In patients with gestational diabetes mell
itus vanadate increased insulin receptor and insulin receptor substrate 1 t
yrosine phosphorylation, but these values remained less than in muscle tiss
ues from nonpregnant control subjects (P < .05). Protein-tyrosine phosphata
se 1B levels were not significantly different in skeletal muscles from each
group.
CONCLUSION: Vanadate did not restore normal glucose transport activity duri
ng pregnancy complicated by gestational diabetes mellitus, which indicates
that decreased glucose uptake is probably not caused by impaired tyrosine p
hosphorylation events alone. Increased serine kinase activity and impaired
glucose transporter 4 translocation probably contribute to insulin signalin
g abnormalities associated with pregnancy, especially in patients with gest
ational diabetes mellitus.